Global Coronary Artery Bypass Graft Procedures Market Size, Share & Trends Analysis Report By Graft Type (Saphenous Vein Grafts, Internal Thoracic Artery Grafts, Other Grafts {Radial Artery, Gastroepiploic Artery}), By Surgery Type (Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, Quadruple CABG Surgery), By Products and Services (Grafts, Retractors, Services, Others), By End Users (Hospitals, Cardiology Clinics, Other End Users) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Forecast (2024-2032). The report offers the value (in USD Billion) for the above segments.

Market Overview:

The Global Coronary Artery Bypass Grafting Procedures Market is estimated to be valued at USD 14.02 Billion in 2024 and is expected to reach USD 28.56 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2024 to 2032.

The Global Coronary Artery Bypass Graft (CABG) Procedures Market is one of the most important segments of the cardiovascular surgical domain, driven by the continuously increasing prevalence of coronary artery disease (CAD) worldwide. CABG is a procedure that aims to improve blood flow towards the heart by bypassing narrowed or blocked coronary arteries through a graft, which are usually harvested from the patient's leg, arm, or chest. The lifeline procedure is mainly advised for patients with severe cases of coronary artery disease particularly when other, less intrusive treatments such as angioplasty or stenting are viewed as insufficient.

Cardiovascular diseases, including coronary artery disease, rank among the top causes of death around the world. With the incidence of lifestyle-related conditions like obesity, diabetes, and hypertension, largely caused by poor dietary habits, sedentary lifestyles, and smoking, the burden of coronary artery disease has increased, and the CABG procedure is in increasing demand. Further significant steps in the growth of the extent of CABG procedures come along the way of technology advancement with improvements in cardiac surgery and diagnostic techniques. Development of minimum invasive surgical methods, robots-assisted surgical procedures, new and advanced graft materials have allowed less recovery time after surgery as well as minimum post-surgery complications, so CABG is accessible for patients at all levels globally.

One other key driver of CABG procedures market growth is an aging global population. In an aging population, more people are likely to get coronary artery disease as compared to younger populations, resulting in a higher demand for surgical interventions such as CABG. Furthermore, awareness towards cardiovascular health, earlier detection of heart conditions, and infrastructural progress of healthcare has also fuelled the demand for such surgeries. This is now becoming a focal point for most healthcare systems to improve access to cardiac care, which leads to the surge in CABG surgery in emerging markets where facilities are expanding.

Although the CABG procedure is witnessing growth, it has associated challenges. Among the main restrictions is the increasing tendency toward less invasive procedures, including stenting and other forms of PCI. These may mean that, although effective in certain patients, they can bring about a reduced number of individuals who would require CABG in the first place. Also related to this, CABG is associated with high costs, which are likely to be limiting patient access in low-income healthcare nations or countries where insurance is difficult to access.

However, the CABG procedures market is still growing steadily because of the need for surgeries in complex cases in which other treatments are inadequate. The ongoing research on perfecting surgical techniques and post-surgical care, as well as the increased use of hybrid procedures that combine CABG with PCI, continues to offer promising prospects to the market.

Market Dynamics - Market Drivers

Increasing Prevalence of Coronary Artery Disease

• Global surge in the occurrence of coronary artery disease (CAD) forms a key factor that accelerates the demand in the CABG procedures market. Improper diets, insufficient exercises, smoking, and heightened stress lead to a prevalence of more risk factors, such as obesity, hypertension, and diabetes, hence developing CAD and severe occurrences demand surgical interference. As the global burden of CAD increases even with increasing age, the incidence for CABG grows; and hence, the operation is seen as one such timely solution for those patients who have complex or extensive blockages and cannot be treated with less invasive methods.

Advancements in Cardiac Surgical Techniques

• Advancements in technologies related to cardiac surgery drive the CABG procedures market. The developments in minimally invasive techniques, robotic-assisted surgeries, and better imaging are enhancing the precision and the safety of CABG. These advances not only avoid the risks associated with traditional open-heart surgeries but also reduce recovery times, and post-operative complications and improve patient outcome. Improvements in the materials used for grafting and postoperative care ensure better outcomes and durability with every procedure, thus increasingly patients and physicians are opting for CABG in severe conditions of coronary artery disease.

Market Opportunities

Expansion of Healthcare Infrastructure in Emerging Markets

• The developing markets, especially in Asia, Latin America, and the Middle East, hold significant growth opportunities for the CABG procedures market. In these regions, improving health care infrastructure allows more patients to access advanced cardiac care, including CABG procedures. The investment of governments in health care facilities, medical equipment, and training programs for cardiovascular surgeons facilitates a greater number of CABG surgeries. In these regions, the growing middle class and rising healthcare awareness have greatly contributed to the increased demand for advanced cardiac treatment.

Technological Innovations in Grafting Materials

• Sustainable improvements in grafting materials in CABG procedures are a next potential growth opportunity. Grafts with increased strength, durability, and biocompatibility are being developed for their application in CABG procedures, such as new-generation synthetic grafts, bioengineered materials, and tissue-engineered grafts. Such new materials shall prevent graft rejection risks and eventually contribute to improved patient long-term outcomes and success of the CABG procedure. These innovations are likely to make CABG more available, efficient, and acceptable to surgeons and patients; therefore, they should augment market growth.

Market Restraining Factors

Growing Preference for Minimally Invasive Procedures

• The growing adoption of minimally invasive procedures, such as PCI, that include angioplasty and stenting has become a challenge for the CABG procedures market. The less invasive nature of PCI makes it more desirable for milder cases of coronary artery disease due to the shorter period of hospital stay and shorter recovery times. Technological advancements in stenting and angioplasty have only created more alternatives for many patients and physicians, which decreases the overall market demand for CABG.

High Cost of CABG Surgeries

• The high cost always related to CABG procedures always poses a significant restraint within the regions with limited sources of healthcare funding or simply where insurance coverage is inadequate. There are CABG surgeries involving complexity in procedures, extended hospitalization periods, and costs paid for grafting materials with post-operative care. In many underdeveloped countries or regions without developed healthcare infrastructure, high-priced CABG procedures can reach a portion of the population, hence limiting market growth. Additionally, costs may discourage a patient from seeking CABG as stenting, which costs much less and is also minimally invasive, will suffice.

Segmentation Analysis

The market scope is segmented because of by Graft Type, by Surgery Type, by Products and Services, by End Users.

By Graft Type

Based on the Graft Type of the market is segmented into Saphenous Vein Grafts, Internal Thoracic Artery Grafts, Other Grafts {Radial Artery, Gastroepiploic Artery}.

Internal Thoracic Artery Grafts segment has emerged as a leader in market share within all types of grafts utilized during CABG operations. The main reason is the long-term patency rates and better clinical results associated with internal thoracic artery grafting compared with other grafting types, including Saphenous Vein Grafting or Radial Artery Grafting. The ITA is preferred, especially the left internal thoracic artery, with excellent durability and reduced risk of occlusion of the graft itself. In fact, studies have generally shown that ITA grafts remain open and functional much longer after surgery, in turn contributing to better patient survival rates and fewer repeat interventions.

Apart from that, ITA grafts have a fewer chance of post-operative complication infection and graft failure leading the surgeons and patients toward favourability. Therefore, all kinds of CABG employ mostly ITA graft. Mainly, in multi-vessel disease of coronary artery when there are so many chances of postoperative outcome, ITA is predominantly used. Although Saphenous Vein Grafts are still utilized as a secondary or supplementary graft, ITA grafts remain the gold standard for primary bypass grafting because of their reliability and proven effectiveness, and hence, will continue to lead in the market.

By Surgery Type

Based on the Surgery Type of the market is segmented into Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, Quadruple CABG Surgery.

Among the segments by surgery type, Quadruple CABG Surgery has traditionally been leading the market for CABG procedures. This is basically because quadruple bypass surgeries are usually performed on patients, who have severe coronary artery disease and where multiple coronary arteries are blocked or narrowed, hence requiring the creation of four separate bypass grafts. With the increasing incidence of coronary artery disease in all parts of the world because of factors such as aging populations, lifestyle-related conditions like obesity, smoking, and sedentary habits, and an increasing burden of diabetes and hypertension, more patients need extensive surgical interventions like quadruple CABG.

In addition, quadruple CABG surgery provides major clinical benefits, as it provides better blood flow to a larger area of the heart, reducing the risk of future cardiac events. Patients with multiple blocked arteries are usually advised to undergo quadruple bypass surgery in order to ensure long-term survival and improved quality of life. Additionally, improved surgical techniques and postoperative care have also rendered quadruple CABG safer and more successful. So, in the marketplace, quadruple CABG still dominates, although lesser invasive surgeries, such as single or double CABG, work well for milder cases of coronary artery disease.

Regional Snapshots

By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. CABG procedures are majorly dominated in North America. This region has the developed healthcare infrastructure along with the high prevalence of coronary artery disease. The region has vast skilled cardiac surgeons and most updated medical technologies available. The United States has experienced a high demand for CABG surgeries, mainly because of lifestyle-related factors like high obesity rates, sedentary living, and dietary habits that increase the risk of CAD. Also, the region has a sound reimbursement system and insurance coverage, thus making expensive procedures like CABG accessible to the patients. A high-aged population that is more likely to experience cardiovascular diseases contributes the most to its supremacy in this market.

The Asia-Pacific region is one of the most likely to show the fastest pace of CABG procedures since it is ahead of the curve as regards rising cardiovascular diseases; improved health care spending; and improvement of health infrastructure is in these countries, most notably China, India, and Japan. More of those countries have invested in more health care, which puts the availability of such advanced heart care such as CABG procedures closer for patients. Furthermore, awareness of CAD, specifically regarding the requirement for early diagnosis and treatment, has been rising in the last few years. In addition to this, the number of people engaged in medical tourism is also on the rise, which further fuels the demand for CABG surgeries in the region. The population base and increasing disposable incomes are the other growth drivers for the CABG procedures market in Asia-Pacific.

List of Companies Profiled

• Terumo Medical Corporation
• Getinge AB
• Genesee Biomedical Inc
• Medtronic PLC
• Karl Storz SE & Co KG
• Scanlan International Inc
• Teleflex Incorporated
• Peter Surgical
• Edwards Lifesciences
• Stryker

Key Industry Developments

In April 2024, the Society of Thoracic Surgeons (STS) introduced new risk calculators for isolated tricuspid valve repair and replacement, surgical aortic valve replacement (SAVR) following prior transcatheter aortic valve replacement (TAVR), and multi-valve surgeries with or without coronary artery bypass grafting (CABG)

In August 2022, Medtronic plc, a medical device company, announced its acquisition of Affera, Inc., enhancing its cardiac ablation portfolio with its first comprehensive cardiac mapping and navigation platform. This new platform integrates a distinctive combination of diagnostic tools, focal pulsed field ablation, and radiofrequency ablation solutions.

In August 2022, Grand Pharmaceutical Group of China invested EUR 15 million in Xeltis, a renowned medical device firm with its clinical-stage headquarters in the Netherlands. Grand Pharmaceutical has created a polymer-based restorative device for cardiovascular treatment. Heart valves and tiny diameter blood arteries are the restoration devices used in CABG surgery.

Report Coverage

The report will cover the qualitative and quantitative data on the global Coronary Artery Bypass Graft Procedures Market. The qualitative data includes latest trends, market players’ analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Regional Analysis

North America accounted for the highest xx% market share in terms of revenue in the Coronary Artery Bypass Graft Procedures market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Coronary Artery Bypass Graft Procedures. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Coronary Artery Bypass Graft Procedures companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Coronary Artery Bypass Graft Procedures Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Coronary Artery Bypass Graft Procedures Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Questions

• How much the global Coronary Artery Bypass Graft Procedures Market valued?
• Which region has the largest share in 2024 for the global Coronary Artery Bypass Graft Procedures Market?
• What are the driving factors for the market?
• Which is the leading segment in the global market?
• What are the major players in the market?

Research Scope of Coronary Artery Bypass Graft Procedures Market

• Historic year: 2019-2022
• Base year: 2023
• Forecast: 2024 to 2032
• Representation of Market revenue in USD Billion

Coronary Artery Bypass Graft Procedures Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: